Bay Colony Advisory Group, Inc D Moderna, Inc. Transaction History

Bay Colony Advisory Group, Inc D

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$85.37 - $115.44 $19,805 - $26,782	232 Added 9.43%	2,691 $286,000
Q4 2023 Jan 29, 2024	BUY	$69.51 - $104.43 $10,496 - $15,768	151 Added 6.54%	2,459 $244,000
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $28,248 - $37,096	-293 Reduced 11.26%	2,308 $238,000
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $41,712 - $56,506	-352 Reduced 11.92%	2,601 $316,000
Q1 2023 Apr 27, 2023	BUY	$135.66 - $197.02 $13,430 - $19,504	99 Added 3.47%	2,953 $453,000
Q4 2022 Feb 01, 2023	BUY	$118.38 - $210.04 $8,404 - $14,912	71 Added 2.55%	2,854 $512,000
Q3 2022 Oct 27, 2022	BUY	$118.07 - $194.18 $5,903 - $9,709	50 Added 1.83%	2,783 $329,000
Q2 2022 Aug 08, 2022	BUY	$117.13 - $176.59 $24,480 - $36,907	209 Added 8.28%	2,733 $448,000
Q1 2022 Apr 28, 2022	BUY	$126.46 - $235.05 $198,162 - $368,323	1,567 Added 163.74%	2,524 $435,000
Q4 2021 Jan 28, 2022	BUY	$225.82 - $368.51 $26,646 - $43,484	118 Added 14.06%	957 $243,000
Q3 2021 Nov 02, 2021	SELL	$221.9 - $484.47 $86,541 - $188,943	-390 Reduced 31.73%	839 $323,000
Q2 2021 Jul 22, 2021	BUY	$129.91 - $234.98 $159,659 - $288,790	1,229 New	1,229 $289,000

1,112

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $23.6B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.